nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—S100A1—kidney cancer	0.715	1	CbGaD
Olopatadine—CYP3A4—Everolimus—kidney cancer	0.0264	0.293	CbGbCtD
Olopatadine—CYP3A4—Temsirolimus—kidney cancer	0.0178	0.198	CbGbCtD
Olopatadine—CYP3A4—Pazopanib—kidney cancer	0.00936	0.104	CbGbCtD
Olopatadine—CYP3A4—Erlotinib—kidney cancer	0.00668	0.0741	CbGbCtD
Olopatadine—CYP3A4—Paclitaxel—kidney cancer	0.00611	0.0678	CbGbCtD
Olopatadine—CYP3A4—Sorafenib—kidney cancer	0.00543	0.0603	CbGbCtD
Olopatadine—CYP3A4—Vinblastine—kidney cancer	0.00536	0.0595	CbGbCtD
Olopatadine—CYP3A4—Vincristine—kidney cancer	0.00527	0.0585	CbGbCtD
Olopatadine—CYP3A4—Sunitinib—kidney cancer	0.0044	0.0488	CbGbCtD
Olopatadine—S100A2—nephron tubule—kidney cancer	0.00375	0.111	CbGeAlD
Olopatadine—S100A1—nephron tubule—kidney cancer	0.00346	0.103	CbGeAlD
Olopatadine—S100A2—renal system—kidney cancer	0.00341	0.101	CbGeAlD
Olopatadine—CYP3A4—Doxorubicin—kidney cancer	0.00329	0.0366	CbGbCtD
Olopatadine—S100A2—cortex of kidney—kidney cancer	0.00321	0.0954	CbGeAlD
Olopatadine—S100A1—renal system—kidney cancer	0.00314	0.0933	CbGeAlD
Olopatadine—S100A1—kidney—kidney cancer	0.00304	0.0902	CbGeAlD
Olopatadine—S100A1—cortex of kidney—kidney cancer	0.00296	0.0878	CbGeAlD
Olopatadine—S100A1—cardiac atrium—kidney cancer	0.00281	0.0836	CbGeAlD
Olopatadine—S100A13—renal system—kidney cancer	0.00279	0.0828	CbGeAlD
Olopatadine—S100A13—gonad—kidney cancer	0.0025	0.0742	CbGeAlD
Olopatadine—CYP3A4—urine—kidney cancer	0.00176	0.0522	CbGeAlD
Olopatadine—CYP3A4—renal system—kidney cancer	0.00043	0.0128	CbGeAlD
Olopatadine—CYP3A4—kidney—kidney cancer	0.000416	0.0124	CbGeAlD
Olopatadine—Clomipramine—GSTP1—kidney cancer	0.000202	0.373	CrCbGaD
Olopatadine—Nausea—Pazopanib—kidney cancer	0.000144	0.00135	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000144	0.00134	CcSEcCtD
Olopatadine—Fatigue—Sorafenib—kidney cancer	0.000144	0.00134	CcSEcCtD
Olopatadine—Dyspnoea—Sunitinib—kidney cancer	0.000143	0.00133	CcSEcCtD
Olopatadine—Pain—Sorafenib—kidney cancer	0.000142	0.00133	CcSEcCtD
Olopatadine—Malaise—Gemcitabine—kidney cancer	0.000142	0.00133	CcSEcCtD
Olopatadine—Hypersensitivity—Vinblastine—kidney cancer	0.000142	0.00132	CcSEcCtD
Olopatadine—Eye disorder—Paclitaxel—kidney cancer	0.000142	0.00132	CcSEcCtD
Olopatadine—Weight increased—Capecitabine—kidney cancer	0.000141	0.00132	CcSEcCtD
Olopatadine—Hypersensitivity—Everolimus—kidney cancer	0.000141	0.00132	CcSEcCtD
Olopatadine—Infestation NOS—Capecitabine—kidney cancer	0.000138	0.00129	CcSEcCtD
Olopatadine—Infestation—Capecitabine—kidney cancer	0.000138	0.00129	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000138	0.00129	CcSEcCtD
Olopatadine—Asthenia—Vinblastine—kidney cancer	0.000138	0.00129	CcSEcCtD
Olopatadine—Fatigue—Sunitinib—kidney cancer	0.000138	0.00129	CcSEcCtD
Olopatadine—Depression—Capecitabine—kidney cancer	0.000138	0.00129	CcSEcCtD
Olopatadine—Asthenia—Everolimus—kidney cancer	0.000138	0.00128	CcSEcCtD
Olopatadine—Cough—Gemcitabine—kidney cancer	0.000137	0.00128	CcSEcCtD
Olopatadine—Pain—Sunitinib—kidney cancer	0.000137	0.00128	CcSEcCtD
Olopatadine—Immune system disorder—Paclitaxel—kidney cancer	0.000137	0.00128	CcSEcCtD
Olopatadine—Mediastinal disorder—Paclitaxel—kidney cancer	0.000137	0.00127	CcSEcCtD
Olopatadine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000136	0.00127	CcSEcCtD
Olopatadine—Pruritus—Everolimus—kidney cancer	0.000136	0.00127	CcSEcCtD
Olopatadine—Oedema—Vincristine—kidney cancer	0.000136	0.00126	CcSEcCtD
Olopatadine—Infection—Vincristine—kidney cancer	0.000135	0.00126	CcSEcCtD
Olopatadine—Conjunctivitis—Capecitabine—kidney cancer	0.000135	0.00126	CcSEcCtD
Olopatadine—Urinary tract infection—Capecitabine—kidney cancer	0.000135	0.00126	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000133	0.00124	CcSEcCtD
Olopatadine—Nervous system disorder—Vincristine—kidney cancer	0.000133	0.00124	CcSEcCtD
Olopatadine—Asthenia—Erlotinib—kidney cancer	0.000133	0.00124	CcSEcCtD
Olopatadine—Discomfort—Gemcitabine—kidney cancer	0.000132	0.00124	CcSEcCtD
Olopatadine—Erythema—Paclitaxel—kidney cancer	0.000132	0.00123	CcSEcCtD
Olopatadine—Diarrhoea—Vinblastine—kidney cancer	0.000132	0.00123	CcSEcCtD
Olopatadine—Abdominal pain—Sorafenib—kidney cancer	0.000132	0.00123	CcSEcCtD
Olopatadine—Body temperature increased—Sorafenib—kidney cancer	0.000132	0.00123	CcSEcCtD
Olopatadine—Diarrhoea—Everolimus—kidney cancer	0.000131	0.00123	CcSEcCtD
Olopatadine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000131	0.00122	CcSEcCtD
Olopatadine—Pruritus—Erlotinib—kidney cancer	0.000131	0.00122	CcSEcCtD
Olopatadine—Fatigue—Dactinomycin—kidney cancer	0.000131	0.00122	CcSEcCtD
Olopatadine—Epistaxis—Capecitabine—kidney cancer	0.000131	0.00122	CcSEcCtD
Olopatadine—Pain—Dactinomycin—kidney cancer	0.00013	0.00121	CcSEcCtD
Olopatadine—Dysgeusia—Paclitaxel—kidney cancer	0.000129	0.00121	CcSEcCtD
Olopatadine—Oedema—Gemcitabine—kidney cancer	0.000129	0.0012	CcSEcCtD
Olopatadine—Eye pain—Doxorubicin—kidney cancer	0.000128	0.0012	CcSEcCtD
Olopatadine—Infection—Gemcitabine—kidney cancer	0.000128	0.00119	CcSEcCtD
Olopatadine—Back pain—Paclitaxel—kidney cancer	0.000128	0.00119	CcSEcCtD
Olopatadine—Dizziness—Vinblastine—kidney cancer	0.000127	0.00119	CcSEcCtD
Olopatadine—Dizziness—Everolimus—kidney cancer	0.000127	0.00118	CcSEcCtD
Olopatadine—Muscle spasms—Paclitaxel—kidney cancer	0.000127	0.00118	CcSEcCtD
Olopatadine—Abdominal pain—Sunitinib—kidney cancer	0.000127	0.00118	CcSEcCtD
Olopatadine—Body temperature increased—Sunitinib—kidney cancer	0.000127	0.00118	CcSEcCtD
Olopatadine—Diarrhoea—Erlotinib—kidney cancer	0.000127	0.00118	CcSEcCtD
Olopatadine—Nervous system disorder—Gemcitabine—kidney cancer	0.000126	0.00118	CcSEcCtD
Olopatadine—Feeling abnormal—Dactinomycin—kidney cancer	0.000125	0.00117	CcSEcCtD
Olopatadine—Skin disorder—Gemcitabine—kidney cancer	0.000125	0.00117	CcSEcCtD
Olopatadine—Rhinitis—Capecitabine—kidney cancer	0.000125	0.00116	CcSEcCtD
Olopatadine—Vision blurred—Paclitaxel—kidney cancer	0.000124	0.00116	CcSEcCtD
Olopatadine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000124	0.00116	CcSEcCtD
Olopatadine—Hypoaesthesia—Capecitabine—kidney cancer	0.000124	0.00115	CcSEcCtD
Olopatadine—Pharyngitis—Capecitabine—kidney cancer	0.000123	0.00115	CcSEcCtD
Olopatadine—Hypersensitivity—Sorafenib—kidney cancer	0.000123	0.00115	CcSEcCtD
Olopatadine—Vomiting—Vinblastine—kidney cancer	0.000122	0.00114	CcSEcCtD
Olopatadine—Dizziness—Erlotinib—kidney cancer	0.000122	0.00114	CcSEcCtD
Olopatadine—Ill-defined disorder—Paclitaxel—kidney cancer	0.000122	0.00114	CcSEcCtD
Olopatadine—Vomiting—Everolimus—kidney cancer	0.000122	0.00114	CcSEcCtD
Olopatadine—Rash—Everolimus—kidney cancer	0.000121	0.00113	CcSEcCtD
Olopatadine—Dermatitis—Everolimus—kidney cancer	0.000121	0.00113	CcSEcCtD
Olopatadine—Headache—Vinblastine—kidney cancer	0.000121	0.00113	CcSEcCtD
Olopatadine—Headache—Everolimus—kidney cancer	0.00012	0.00112	CcSEcCtD
Olopatadine—Abdominal pain—Dactinomycin—kidney cancer	0.00012	0.00112	CcSEcCtD
Olopatadine—Body temperature increased—Dactinomycin—kidney cancer	0.00012	0.00112	CcSEcCtD
Olopatadine—Visual impairment—Capecitabine—kidney cancer	0.00012	0.00112	CcSEcCtD
Olopatadine—Asthenia—Sorafenib—kidney cancer	0.000119	0.00112	CcSEcCtD
Olopatadine—Malaise—Paclitaxel—kidney cancer	0.000119	0.00111	CcSEcCtD
Olopatadine—Hypersensitivity—Sunitinib—kidney cancer	0.000118	0.0011	CcSEcCtD
Olopatadine—Pruritus—Sorafenib—kidney cancer	0.000118	0.0011	CcSEcCtD
Olopatadine—Vomiting—Erlotinib—kidney cancer	0.000118	0.0011	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000117	0.00109	CcSEcCtD
Olopatadine—Fatigue—Vincristine—kidney cancer	0.000117	0.00109	CcSEcCtD
Olopatadine—Rash—Erlotinib—kidney cancer	0.000117	0.00109	CcSEcCtD
Olopatadine—Dermatitis—Erlotinib—kidney cancer	0.000117	0.00109	CcSEcCtD
Olopatadine—Eye disorder—Capecitabine—kidney cancer	0.000116	0.00108	CcSEcCtD
Olopatadine—Headache—Erlotinib—kidney cancer	0.000116	0.00108	CcSEcCtD
Olopatadine—Pain—Vincristine—kidney cancer	0.000116	0.00108	CcSEcCtD
Olopatadine—Cough—Paclitaxel—kidney cancer	0.000115	0.00107	CcSEcCtD
Olopatadine—Asthenia—Sunitinib—kidney cancer	0.000115	0.00107	CcSEcCtD
Olopatadine—Dyspnoea—Gemcitabine—kidney cancer	0.000115	0.00107	CcSEcCtD
Olopatadine—Nausea—Vinblastine—kidney cancer	0.000114	0.00107	CcSEcCtD
Olopatadine—Somnolence—Gemcitabine—kidney cancer	0.000114	0.00107	CcSEcCtD
Olopatadine—Nausea—Everolimus—kidney cancer	0.000114	0.00106	CcSEcCtD
Olopatadine—Diarrhoea—Sorafenib—kidney cancer	0.000114	0.00106	CcSEcCtD
Olopatadine—Pruritus—Sunitinib—kidney cancer	0.000113	0.00106	CcSEcCtD
Olopatadine—Immune system disorder—Capecitabine—kidney cancer	0.000112	0.00105	CcSEcCtD
Olopatadine—Mediastinal disorder—Capecitabine—kidney cancer	0.000112	0.00105	CcSEcCtD
Olopatadine—Hypersensitivity—Dactinomycin—kidney cancer	0.000112	0.00104	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000111	0.00104	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000111	0.00104	CcSEcCtD
Olopatadine—Discomfort—Paclitaxel—kidney cancer	0.000111	0.00104	CcSEcCtD
Olopatadine—Fatigue—Gemcitabine—kidney cancer	0.000111	0.00103	CcSEcCtD
Olopatadine—Gastrointestinal pain—Vincristine—kidney cancer	0.000111	0.00103	CcSEcCtD
Olopatadine—Dizziness—Sorafenib—kidney cancer	0.00011	0.00103	CcSEcCtD
Olopatadine—Pain—Gemcitabine—kidney cancer	0.00011	0.00103	CcSEcCtD
Olopatadine—Nausea—Erlotinib—kidney cancer	0.00011	0.00103	CcSEcCtD
Olopatadine—Dry mouth—Paclitaxel—kidney cancer	0.00011	0.00103	CcSEcCtD
Olopatadine—Diarrhoea—Sunitinib—kidney cancer	0.00011	0.00102	CcSEcCtD
Olopatadine—Nortriptyline—PTGS1—kidney cancer	0.000109	0.202	CrCbGaD
Olopatadine—Asthenia—Dactinomycin—kidney cancer	0.000109	0.00102	CcSEcCtD
Olopatadine—Erythema—Capecitabine—kidney cancer	0.000108	0.00101	CcSEcCtD
Olopatadine—Oedema—Paclitaxel—kidney cancer	0.000108	0.001	CcSEcCtD
Olopatadine—Abdominal pain—Vincristine—kidney cancer	0.000107	0.001	CcSEcCtD
Olopatadine—Body temperature increased—Vincristine—kidney cancer	0.000107	0.001	CcSEcCtD
Olopatadine—Infection—Paclitaxel—kidney cancer	0.000107	0.000998	CcSEcCtD
Olopatadine—Dry skin—Doxorubicin—kidney cancer	0.000106	0.000991	CcSEcCtD
Olopatadine—Dysgeusia—Capecitabine—kidney cancer	0.000106	0.000989	CcSEcCtD
Olopatadine—Dizziness—Sunitinib—kidney cancer	0.000106	0.000989	CcSEcCtD
Olopatadine—Feeling abnormal—Gemcitabine—kidney cancer	0.000106	0.000989	CcSEcCtD
Olopatadine—Vomiting—Sorafenib—kidney cancer	0.000106	0.000988	CcSEcCtD
Olopatadine—Nervous system disorder—Paclitaxel—kidney cancer	0.000106	0.000985	CcSEcCtD
Olopatadine—Rash—Sorafenib—kidney cancer	0.000105	0.00098	CcSEcCtD
Olopatadine—Dermatitis—Sorafenib—kidney cancer	0.000105	0.000979	CcSEcCtD
Olopatadine—Back pain—Capecitabine—kidney cancer	0.000105	0.000977	CcSEcCtD
Olopatadine—Skin disorder—Paclitaxel—kidney cancer	0.000105	0.000976	CcSEcCtD
Olopatadine—Headache—Sorafenib—kidney cancer	0.000104	0.000974	CcSEcCtD
Olopatadine—Muscle spasms—Capecitabine—kidney cancer	0.000104	0.000971	CcSEcCtD
Olopatadine—Diarrhoea—Dactinomycin—kidney cancer	0.000104	0.000969	CcSEcCtD
Olopatadine—Nasopharyngitis—Doxorubicin—kidney cancer	0.000104	0.000967	CcSEcCtD
Olopatadine—Vision blurred—Capecitabine—kidney cancer	0.000102	0.000952	CcSEcCtD
Olopatadine—Vomiting—Sunitinib—kidney cancer	0.000102	0.000951	CcSEcCtD
Olopatadine—Body temperature increased—Gemcitabine—kidney cancer	0.000102	0.000949	CcSEcCtD
Olopatadine—Rash—Sunitinib—kidney cancer	0.000101	0.000943	CcSEcCtD
Olopatadine—Dermatitis—Sunitinib—kidney cancer	0.000101	0.000942	CcSEcCtD
Olopatadine—Ill-defined disorder—Capecitabine—kidney cancer	0.0001	0.000937	CcSEcCtD
Olopatadine—Headache—Sunitinib—kidney cancer	0.0001	0.000937	CcSEcCtD
Olopatadine—Influenza—Doxorubicin—kidney cancer	0.0001	0.000935	CcSEcCtD
Olopatadine—Hypersensitivity—Vincristine—kidney cancer	9.98e-05	0.000932	CcSEcCtD
Olopatadine—Nausea—Sorafenib—kidney cancer	9.89e-05	0.000923	CcSEcCtD
Olopatadine—Malaise—Capecitabine—kidney cancer	9.76e-05	0.000911	CcSEcCtD
Olopatadine—Asthenia—Vincristine—kidney cancer	9.72e-05	0.000908	CcSEcCtD
Olopatadine—Vomiting—Dactinomycin—kidney cancer	9.64e-05	0.0009	CcSEcCtD
Olopatadine—Dyspnoea—Paclitaxel—kidney cancer	9.6e-05	0.000896	CcSEcCtD
Olopatadine—Somnolence—Paclitaxel—kidney cancer	9.57e-05	0.000893	CcSEcCtD
Olopatadine—Rash—Dactinomycin—kidney cancer	9.56e-05	0.000893	CcSEcCtD
Olopatadine—Nausea—Sunitinib—kidney cancer	9.52e-05	0.000888	CcSEcCtD
Olopatadine—Cough—Capecitabine—kidney cancer	9.44e-05	0.000882	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Doxorubicin—kidney cancer	9.3e-05	0.000869	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Paclitaxel—kidney cancer	9.29e-05	0.000867	CcSEcCtD
Olopatadine—Fatigue—Paclitaxel—kidney cancer	9.28e-05	0.000866	CcSEcCtD
Olopatadine—Diarrhoea—Vincristine—kidney cancer	9.27e-05	0.000866	CcSEcCtD
Olopatadine—Asthenia—Gemcitabine—kidney cancer	9.22e-05	0.000861	CcSEcCtD
Olopatadine—Pain—Paclitaxel—kidney cancer	9.2e-05	0.000859	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	9.15e-05	0.000854	CcSEcCtD
Olopatadine—Weight increased—Doxorubicin—kidney cancer	9.11e-05	0.000851	CcSEcCtD
Olopatadine—Discomfort—Capecitabine—kidney cancer	9.1e-05	0.00085	CcSEcCtD
Olopatadine—Pruritus—Gemcitabine—kidney cancer	9.09e-05	0.000849	CcSEcCtD
Olopatadine—Dry mouth—Capecitabine—kidney cancer	9.01e-05	0.000841	CcSEcCtD
Olopatadine—Nausea—Dactinomycin—kidney cancer	9.01e-05	0.000841	CcSEcCtD
Olopatadine—Dizziness—Vincristine—kidney cancer	8.96e-05	0.000837	CcSEcCtD
Olopatadine—Infestation NOS—Doxorubicin—kidney cancer	8.93e-05	0.000833	CcSEcCtD
Olopatadine—Infestation—Doxorubicin—kidney cancer	8.93e-05	0.000833	CcSEcCtD
Olopatadine—Feeling abnormal—Paclitaxel—kidney cancer	8.87e-05	0.000828	CcSEcCtD
Olopatadine—Oedema—Capecitabine—kidney cancer	8.83e-05	0.000825	CcSEcCtD
Olopatadine—Gastrointestinal pain—Paclitaxel—kidney cancer	8.8e-05	0.000822	CcSEcCtD
Olopatadine—Diarrhoea—Gemcitabine—kidney cancer	8.8e-05	0.000821	CcSEcCtD
Olopatadine—Infection—Capecitabine—kidney cancer	8.77e-05	0.000819	CcSEcCtD
Olopatadine—Conjunctivitis—Doxorubicin—kidney cancer	8.68e-05	0.00081	CcSEcCtD
Olopatadine—Urinary tract infection—Doxorubicin—kidney cancer	8.68e-05	0.00081	CcSEcCtD
Olopatadine—Nervous system disorder—Capecitabine—kidney cancer	8.66e-05	0.000809	CcSEcCtD
Olopatadine—Vomiting—Vincristine—kidney cancer	8.62e-05	0.000804	CcSEcCtD
Olopatadine—Skin disorder—Capecitabine—kidney cancer	8.58e-05	0.000801	CcSEcCtD
Olopatadine—Rash—Vincristine—kidney cancer	8.54e-05	0.000798	CcSEcCtD
Olopatadine—Dermatitis—Vincristine—kidney cancer	8.54e-05	0.000797	CcSEcCtD
Olopatadine—Abdominal pain—Paclitaxel—kidney cancer	8.51e-05	0.000794	CcSEcCtD
Olopatadine—Body temperature increased—Paclitaxel—kidney cancer	8.51e-05	0.000794	CcSEcCtD
Olopatadine—Headache—Vincristine—kidney cancer	8.49e-05	0.000792	CcSEcCtD
Olopatadine—Epistaxis—Doxorubicin—kidney cancer	8.42e-05	0.000786	CcSEcCtD
Olopatadine—Sinusitis—Doxorubicin—kidney cancer	8.37e-05	0.000782	CcSEcCtD
Olopatadine—Vomiting—Gemcitabine—kidney cancer	8.17e-05	0.000763	CcSEcCtD
Olopatadine—Rash—Gemcitabine—kidney cancer	8.1e-05	0.000757	CcSEcCtD
Olopatadine—Dermatitis—Gemcitabine—kidney cancer	8.1e-05	0.000756	CcSEcCtD
Olopatadine—Headache—Gemcitabine—kidney cancer	8.05e-05	0.000752	CcSEcCtD
Olopatadine—Nausea—Vincristine—kidney cancer	8.05e-05	0.000751	CcSEcCtD
Olopatadine—Rhinitis—Doxorubicin—kidney cancer	8.03e-05	0.00075	CcSEcCtD
Olopatadine—Hypoaesthesia—Doxorubicin—kidney cancer	7.97e-05	0.000744	CcSEcCtD
Olopatadine—Pharyngitis—Doxorubicin—kidney cancer	7.95e-05	0.000742	CcSEcCtD
Olopatadine—Hypersensitivity—Paclitaxel—kidney cancer	7.93e-05	0.00074	CcSEcCtD
Olopatadine—Dyspnoea—Capecitabine—kidney cancer	7.87e-05	0.000735	CcSEcCtD
Olopatadine—Visual impairment—Doxorubicin—kidney cancer	7.72e-05	0.000721	CcSEcCtD
Olopatadine—Asthenia—Paclitaxel—kidney cancer	7.72e-05	0.000721	CcSEcCtD
Olopatadine—Nausea—Gemcitabine—kidney cancer	7.64e-05	0.000713	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Capecitabine—kidney cancer	7.62e-05	0.000712	CcSEcCtD
Olopatadine—Fatigue—Capecitabine—kidney cancer	7.61e-05	0.000711	CcSEcCtD
Olopatadine—Pruritus—Paclitaxel—kidney cancer	7.61e-05	0.000711	CcSEcCtD
Olopatadine—Pain—Capecitabine—kidney cancer	7.55e-05	0.000705	CcSEcCtD
Olopatadine—Eye disorder—Doxorubicin—kidney cancer	7.49e-05	0.000699	CcSEcCtD
Olopatadine—Diarrhoea—Paclitaxel—kidney cancer	7.36e-05	0.000687	CcSEcCtD
Olopatadine—Feeling abnormal—Capecitabine—kidney cancer	7.28e-05	0.000679	CcSEcCtD
Olopatadine—Immune system disorder—Doxorubicin—kidney cancer	7.24e-05	0.000676	CcSEcCtD
Olopatadine—Gastrointestinal pain—Capecitabine—kidney cancer	7.22e-05	0.000674	CcSEcCtD
Olopatadine—Mediastinal disorder—Doxorubicin—kidney cancer	7.22e-05	0.000674	CcSEcCtD
Olopatadine—Dizziness—Paclitaxel—kidney cancer	7.12e-05	0.000664	CcSEcCtD
Olopatadine—Abdominal pain—Capecitabine—kidney cancer	6.98e-05	0.000652	CcSEcCtD
Olopatadine—Body temperature increased—Capecitabine—kidney cancer	6.98e-05	0.000652	CcSEcCtD
Olopatadine—Erythema—Doxorubicin—kidney cancer	6.98e-05	0.000651	CcSEcCtD
Olopatadine—Vomiting—Paclitaxel—kidney cancer	6.84e-05	0.000639	CcSEcCtD
Olopatadine—Dysgeusia—Doxorubicin—kidney cancer	6.83e-05	0.000638	CcSEcCtD
Olopatadine—Rash—Paclitaxel—kidney cancer	6.79e-05	0.000633	CcSEcCtD
Olopatadine—Dermatitis—Paclitaxel—kidney cancer	6.78e-05	0.000633	CcSEcCtD
Olopatadine—Back pain—Doxorubicin—kidney cancer	6.75e-05	0.00063	CcSEcCtD
Olopatadine—Headache—Paclitaxel—kidney cancer	6.74e-05	0.000629	CcSEcCtD
Olopatadine—Muscle spasms—Doxorubicin—kidney cancer	6.71e-05	0.000626	CcSEcCtD
Olopatadine—Vision blurred—Doxorubicin—kidney cancer	6.57e-05	0.000614	CcSEcCtD
Olopatadine—Hypersensitivity—Capecitabine—kidney cancer	6.51e-05	0.000607	CcSEcCtD
Olopatadine—Ill-defined disorder—Doxorubicin—kidney cancer	6.47e-05	0.000604	CcSEcCtD
Olopatadine—Nausea—Paclitaxel—kidney cancer	6.39e-05	0.000597	CcSEcCtD
Olopatadine—Asthenia—Capecitabine—kidney cancer	6.34e-05	0.000592	CcSEcCtD
Olopatadine—Malaise—Doxorubicin—kidney cancer	6.29e-05	0.000587	CcSEcCtD
Olopatadine—Pruritus—Capecitabine—kidney cancer	6.25e-05	0.000583	CcSEcCtD
Olopatadine—Cough—Doxorubicin—kidney cancer	6.09e-05	0.000568	CcSEcCtD
Olopatadine—Diarrhoea—Capecitabine—kidney cancer	6.04e-05	0.000564	CcSEcCtD
Olopatadine—HRH1—GPCR downstream signaling—OR4C13—kidney cancer	5.94e-05	0.00111	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	5.9e-05	0.000551	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—SFRP2—kidney cancer	5.88e-05	0.0011	CbGpPWpGaD
Olopatadine—Discomfort—Doxorubicin—kidney cancer	5.87e-05	0.000548	CcSEcCtD
Olopatadine—Dizziness—Capecitabine—kidney cancer	5.84e-05	0.000545	CcSEcCtD
Olopatadine—Dry mouth—Doxorubicin—kidney cancer	5.81e-05	0.000542	CcSEcCtD
Olopatadine—S100A12—Immune System—CTSB—kidney cancer	5.72e-05	0.00107	CbGpPWpGaD
Olopatadine—Oedema—Doxorubicin—kidney cancer	5.69e-05	0.000531	CcSEcCtD
Olopatadine—S100A12—Immune System—CTSD—kidney cancer	5.69e-05	0.00106	CbGpPWpGaD
Olopatadine—Infection—Doxorubicin—kidney cancer	5.66e-05	0.000528	CcSEcCtD
Olopatadine—Vomiting—Capecitabine—kidney cancer	5.62e-05	0.000524	CcSEcCtD
Olopatadine—Nervous system disorder—Doxorubicin—kidney cancer	5.58e-05	0.000521	CcSEcCtD
Olopatadine—Rash—Capecitabine—kidney cancer	5.57e-05	0.00052	CcSEcCtD
Olopatadine—Dermatitis—Capecitabine—kidney cancer	5.56e-05	0.000519	CcSEcCtD
Olopatadine—Headache—Capecitabine—kidney cancer	5.53e-05	0.000517	CcSEcCtD
Olopatadine—Skin disorder—Doxorubicin—kidney cancer	5.53e-05	0.000516	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—TSC2—kidney cancer	5.53e-05	0.00103	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PSMD7—kidney cancer	5.53e-05	0.00103	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	5.52e-05	0.00103	CbGpPWpGaD
Olopatadine—Clomipramine—ABCB1—kidney cancer	5.43e-05	0.1	CrCbGaD
Olopatadine—S100B—Immune System—CTSB—kidney cancer	5.41e-05	0.00101	CbGpPWpGaD
Olopatadine—Chlorprothixene—ABCB1—kidney cancer	5.41e-05	0.1	CrCbGaD
Olopatadine—HRH1—Signaling by GPCR—OR4C13—kidney cancer	5.4e-05	0.00101	CbGpPWpGaD
Olopatadine—S100B—Immune System—CTSD—kidney cancer	5.38e-05	0.001	CbGpPWpGaD
Olopatadine—Nausea—Capecitabine—kidney cancer	5.25e-05	0.00049	CcSEcCtD
Olopatadine—S100B—Innate Immune System—TSC2—kidney cancer	5.23e-05	0.000975	CbGpPWpGaD
Olopatadine—S100B—Immune System—PSMD7—kidney cancer	5.23e-05	0.000974	CbGpPWpGaD
Olopatadine—Dyspnoea—Doxorubicin—kidney cancer	5.08e-05	0.000474	CcSEcCtD
Olopatadine—Somnolence—Doxorubicin—kidney cancer	5.06e-05	0.000472	CcSEcCtD
Olopatadine—S100A12—Immune System—PAK1—kidney cancer	4.96e-05	0.000925	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	4.92e-05	0.000917	CbGpPWpGaD
Olopatadine—Gastrointestinal disorder—Doxorubicin—kidney cancer	4.92e-05	0.000459	CcSEcCtD
Olopatadine—Fatigue—Doxorubicin—kidney cancer	4.91e-05	0.000458	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—KIT—kidney cancer	4.88e-05	0.000911	CbGpPWpGaD
Olopatadine—Pain—Doxorubicin—kidney cancer	4.87e-05	0.000454	CcSEcCtD
Olopatadine—HRH1—IL-4 Signaling Pathway—MAPK3—kidney cancer	4.85e-05	0.000905	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNA1—kidney cancer	4.84e-05	0.000902	CbGpPWpGaD
Olopatadine—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	4.84e-05	0.000902	CbGpPWpGaD
Olopatadine—Doxepin—ABCB1—kidney cancer	4.76e-05	0.088	CrCbGaD
Olopatadine—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	4.75e-05	0.000885	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKAP13—kidney cancer	4.74e-05	0.000884	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CASP2—kidney cancer	4.74e-05	0.000884	CbGpPWpGaD
Olopatadine—Feeling abnormal—Doxorubicin—kidney cancer	4.69e-05	0.000438	CcSEcCtD
Olopatadine—S100B—Immune System—PAK1—kidney cancer	4.69e-05	0.000875	CbGpPWpGaD
Olopatadine—Gastrointestinal pain—Doxorubicin—kidney cancer	4.66e-05	0.000435	CcSEcCtD
Olopatadine—S100A12—Immune System—EGR1—kidney cancer	4.64e-05	0.000865	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—MAPK1—kidney cancer	4.62e-05	0.000861	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—KIT—kidney cancer	4.62e-05	0.000861	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNA1—kidney cancer	4.58e-05	0.000853	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNA2—kidney cancer	4.5e-05	0.00084	CbGpPWpGaD
Olopatadine—Body temperature increased—Doxorubicin—kidney cancer	4.5e-05	0.00042	CcSEcCtD
Olopatadine—Abdominal pain—Doxorubicin—kidney cancer	4.5e-05	0.00042	CcSEcCtD
Olopatadine—S100B—Immune System—EGR1—kidney cancer	4.39e-05	0.000818	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GRB7—kidney cancer	4.34e-05	0.000809	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNA2—kidney cancer	4.26e-05	0.000794	CbGpPWpGaD
Olopatadine—Hypersensitivity—Doxorubicin—kidney cancer	4.19e-05	0.000392	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	4.09e-05	0.000762	CbGpPWpGaD
Olopatadine—Asthenia—Doxorubicin—kidney cancer	4.08e-05	0.000381	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—ITPR2—kidney cancer	4.03e-05	0.000752	CbGpPWpGaD
Olopatadine—Pruritus—Doxorubicin—kidney cancer	4.03e-05	0.000376	CcSEcCtD
Olopatadine—HRH1—IL-4 Signaling Pathway—PIK3CA—kidney cancer	4.01e-05	0.000747	CbGpPWpGaD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	3.91e-05	0.000729	CbGpPWpGaD
Olopatadine—Diarrhoea—Doxorubicin—kidney cancer	3.9e-05	0.000364	CcSEcCtD
Olopatadine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	3.86e-05	0.00072	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—RAF1—kidney cancer	3.83e-05	0.000715	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—RELA—kidney cancer	3.82e-05	0.000711	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—ERBB2—kidney cancer	3.79e-05	0.000707	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD8A—kidney cancer	3.79e-05	0.000706	CbGpPWpGaD
Olopatadine—Dizziness—Doxorubicin—kidney cancer	3.76e-05	0.000351	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—MTOR—kidney cancer	3.74e-05	0.000698	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CD4—kidney cancer	3.73e-05	0.000696	CbGpPWpGaD
Olopatadine—Imipramine—ABCB1—kidney cancer	3.71e-05	0.0685	CrCbGaD
Olopatadine—Amitriptyline—ABCB1—kidney cancer	3.68e-05	0.0681	CrCbGaD
Olopatadine—S100B—Signaling Pathways—CTNNA1—kidney cancer	3.65e-05	0.000682	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HSPB1—kidney cancer	3.63e-05	0.000678	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EIF4EBP1—kidney cancer	3.63e-05	0.000678	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—RAF1—kidney cancer	3.62e-05	0.000676	CbGpPWpGaD
Olopatadine—Vomiting—Doxorubicin—kidney cancer	3.62e-05	0.000338	CcSEcCtD
Olopatadine—S100B—Innate Immune System—RELA—kidney cancer	3.61e-05	0.000673	CbGpPWpGaD
Olopatadine—Rash—Doxorubicin—kidney cancer	3.59e-05	0.000335	CcSEcCtD
Olopatadine—Dermatitis—Doxorubicin—kidney cancer	3.59e-05	0.000335	CcSEcCtD
Olopatadine—S100B—Innate Immune System—ERBB2—kidney cancer	3.59e-05	0.000669	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD8A—kidney cancer	3.58e-05	0.000668	CbGpPWpGaD
Olopatadine—Headache—Doxorubicin—kidney cancer	3.57e-05	0.000333	CcSEcCtD
Olopatadine—S100B—Innate Immune System—MTOR—kidney cancer	3.54e-05	0.00066	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CD4—kidney cancer	3.53e-05	0.000659	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CDKN1B—kidney cancer	3.51e-05	0.000655	CbGpPWpGaD
Olopatadine—Nausea—Doxorubicin—kidney cancer	3.38e-05	0.000316	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—PSMD7—kidney cancer	3.38e-05	0.00063	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ANXA1—kidney cancer	3.38e-05	0.00063	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TSC1—kidney cancer	3.38e-05	0.00063	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—JUN—kidney cancer	3.34e-05	0.000623	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CDKN1B—kidney cancer	3.32e-05	0.000619	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CTNNB1—kidney cancer	3.32e-05	0.000619	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—FLT1—kidney cancer	3.27e-05	0.00061	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PTEN—kidney cancer	3.23e-05	0.000603	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TSC2—kidney cancer	3.22e-05	0.0006	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—OR4C13—kidney cancer	3.19e-05	0.000595	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	3.17e-05	0.000591	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—JUN—kidney cancer	3.16e-05	0.000589	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CTNNB1—kidney cancer	3.14e-05	0.000585	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—ANXA1—kidney cancer	3.11e-05	0.00058	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PTEN—kidney cancer	3.06e-05	0.00057	CbGpPWpGaD
Olopatadine—S100B—Immune System—TSC2—kidney cancer	3.05e-05	0.000568	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PAK1—kidney cancer	3.03e-05	0.000566	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—JUNB—kidney cancer	3.03e-05	0.000566	CbGpPWpGaD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.92e-05	0.000544	CbGpPWpGaD
Olopatadine—S100A12—Immune System—KIT—kidney cancer	2.84e-05	0.00053	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.79e-05	0.00052	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—MAPK3—kidney cancer	2.76e-05	0.000515	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LATS1—kidney cancer	2.71e-05	0.000506	CbGpPWpGaD
Olopatadine—S100B—Immune System—KIT—kidney cancer	2.69e-05	0.000501	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—MAPK1—kidney cancer	2.63e-05	0.00049	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDH1—kidney cancer	2.62e-05	0.000488	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.61e-05	0.000487	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—MAPK3—kidney cancer	2.61e-05	0.000487	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—MAPK1—kidney cancer	2.49e-05	0.000463	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—KRAS—kidney cancer	2.48e-05	0.000463	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IGF2—kidney cancer	2.48e-05	0.000462	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDH1—kidney cancer	2.47e-05	0.000462	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CDKN2B—kidney cancer	2.47e-05	0.00046	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKAP13—kidney cancer	2.47e-05	0.00046	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IGF1R—kidney cancer	2.4e-05	0.000447	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.36e-05	0.000441	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—KRAS—kidney cancer	2.35e-05	0.000438	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AMER1—kidney cancer	2.31e-05	0.00043	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PIK3CA—kidney cancer	2.28e-05	0.000425	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKAP13—kidney cancer	2.24e-05	0.000418	CbGpPWpGaD
Olopatadine—S100A12—Immune System—RAF1—kidney cancer	2.23e-05	0.000416	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	2.23e-05	0.000416	CbGpPWpGaD
Olopatadine—S100A12—Immune System—RELA—kidney cancer	2.22e-05	0.000414	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ERBB2—kidney cancer	2.21e-05	0.000412	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MTOR—kidney cancer	2.18e-05	0.000406	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD4—kidney cancer	2.18e-05	0.000406	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PIK3CA—kidney cancer	2.16e-05	0.000402	CbGpPWpGaD
Olopatadine—S100B—Immune System—RAF1—kidney cancer	2.11e-05	0.000394	CbGpPWpGaD
Olopatadine—S100B—Immune System—RELA—kidney cancer	2.1e-05	0.000392	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ITPR2—kidney cancer	2.1e-05	0.000391	CbGpPWpGaD
Olopatadine—S100B—Immune System—ERBB2—kidney cancer	2.09e-05	0.000389	CbGpPWpGaD
Olopatadine—S100B—Immune System—MTOR—kidney cancer	2.06e-05	0.000384	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD4—kidney cancer	2.06e-05	0.000384	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDKN1B—kidney cancer	2.05e-05	0.000381	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	2e-05	0.000373	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2—kidney cancer	2e-05	0.000373	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HIF1A—kidney cancer	1.97e-05	0.000368	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TSC2—kidney cancer	1.97e-05	0.000367	CbGpPWpGaD
Olopatadine—S100A12—Immune System—JUN—kidney cancer	1.95e-05	0.000363	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDKN1B—kidney cancer	1.93e-05	0.000361	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.93e-05	0.00036	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CTNNB1—kidney cancer	1.93e-05	0.00036	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CER1—kidney cancer	1.93e-05	0.00036	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GPC3—kidney cancer	1.93e-05	0.00036	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.91e-05	0.000356	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ITPR2—kidney cancer	1.91e-05	0.000355	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2—kidney cancer	1.89e-05	0.000353	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KDR—kidney cancer	1.89e-05	0.000352	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PTEN—kidney cancer	1.88e-05	0.000351	CbGpPWpGaD
Olopatadine—S100B—Immune System—JUN—kidney cancer	1.84e-05	0.000343	CbGpPWpGaD
Olopatadine—S100B—Immune System—CTNNB1—kidney cancer	1.83e-05	0.000341	CbGpPWpGaD
Olopatadine—S100B—Immune System—PTEN—kidney cancer	1.78e-05	0.000332	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.78e-05	0.000331	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ANXA1—kidney cancer	1.76e-05	0.000328	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.75e-05	0.000327	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KIT—kidney cancer	1.74e-05	0.000324	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APC—kidney cancer	1.74e-05	0.000324	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.68e-05	0.000314	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.66e-05	0.00031	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—POMC—kidney cancer	1.66e-05	0.000309	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SFRP2—kidney cancer	1.64e-05	0.000306	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—BRAF—kidney cancer	1.63e-05	0.000305	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MAPK3—kidney cancer	1.61e-05	0.0003	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	1.61e-05	0.0003	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ANXA1—kidney cancer	1.6e-05	0.000298	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MAPK1—kidney cancer	1.53e-05	0.000285	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	1.53e-05	0.000285	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—POMC—kidney cancer	1.52e-05	0.000284	CbGpPWpGaD
Olopatadine—S100B—Immune System—MAPK3—kidney cancer	1.52e-05	0.000284	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—PIK3CA—kidney cancer	1.48e-05	0.000277	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ACY1—kidney cancer	1.48e-05	0.000276	CbGpPWpGaD
Olopatadine—S100B—Immune System—MAPK1—kidney cancer	1.45e-05	0.00027	CbGpPWpGaD
Olopatadine—S100A12—Immune System—KRAS—kidney cancer	1.45e-05	0.00027	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	1.44e-05	0.000269	CbGpPWpGaD
Olopatadine—S100B—Immune System—KRAS—kidney cancer	1.37e-05	0.000255	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RAF1—kidney cancer	1.36e-05	0.000254	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RELA—kidney cancer	1.36e-05	0.000253	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ERBB2—kidney cancer	1.35e-05	0.000252	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MTOR—kidney cancer	1.33e-05	0.000248	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PIK3CA—kidney cancer	1.33e-05	0.000248	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	1.33e-05	0.000247	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CASP2—kidney cancer	1.32e-05	0.000247	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKAP13—kidney cancer	1.32e-05	0.000247	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PDHB—kidney cancer	1.26e-05	0.000235	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CA—kidney cancer	1.26e-05	0.000234	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—POMC—kidney cancer	1.26e-05	0.000234	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CDKN1B—kidney cancer	1.25e-05	0.000233	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2—kidney cancer	1.22e-05	0.000228	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GRB7—kidney cancer	1.21e-05	0.000226	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCND1—kidney cancer	1.19e-05	0.000222	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—JUN—kidney cancer	1.19e-05	0.000222	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CCBL1—kidney cancer	1.18e-05	0.000221	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CTNNB1—kidney cancer	1.18e-05	0.00022	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTEN—kidney cancer	1.15e-05	0.000215	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ITPR2—kidney cancer	1.13e-05	0.00021	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—kidney cancer	1.04e-05	0.000194	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.03e-05	0.000191	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPAT—kidney cancer	1.03e-05	0.000191	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CTNNA1—kidney cancer	1.02e-05	0.00019	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EIF4EBP1—kidney cancer	1.01e-05	0.000189	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HSPB1—kidney cancer	1.01e-05	0.000189	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAPK3—kidney cancer	9.84e-06	0.000183	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MYC—kidney cancer	9.57e-06	0.000178	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APRT—kidney cancer	9.55e-06	0.000178	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—FH—kidney cancer	9.55e-06	0.000178	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ANXA1—kidney cancer	9.43e-06	0.000176	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PSMD7—kidney cancer	9.43e-06	0.000176	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TSC1—kidney cancer	9.43e-06	0.000176	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAPK1—kidney cancer	9.36e-06	0.000175	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FLT1—kidney cancer	9.14e-06	0.00017	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GPC3—kidney cancer	8.97e-06	0.000167	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KRAS—kidney cancer	8.84e-06	0.000165	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CA2—kidney cancer	8.73e-06	0.000163	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—POMC—kidney cancer	8.62e-06	0.000161	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALAD—kidney cancer	8.51e-06	0.000159	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PAK1—kidney cancer	8.47e-06	0.000158	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JUNB—kidney cancer	8.47e-06	0.000158	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.3e-06	0.000155	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CA—kidney cancer	8.12e-06	0.000151	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.12e-06	0.000151	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TP53—kidney cancer	7.86e-06	0.000147	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—POMC—kidney cancer	7.82e-06	0.000146	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.78e-06	0.000145	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PGK1—kidney cancer	7.78e-06	0.000145	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LDHB—kidney cancer	7.63e-06	0.000142	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF2—kidney cancer	6.92e-06	0.000129	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDKN2B—kidney cancer	6.89e-06	0.000129	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF1R—kidney cancer	6.7e-06	0.000125	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CA9—kidney cancer	6.62e-06	0.000123	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—RAF1—kidney cancer	6.45e-06	0.00012	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2—kidney cancer	6.37e-06	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2—kidney cancer	5.78e-06	0.000108	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CRABP1—kidney cancer	5.63e-06	0.000105	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HIF1A—kidney cancer	5.51e-06	0.000103	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TSC2—kidney cancer	5.5e-06	0.000103	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KDR—kidney cancer	5.27e-06	9.83e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ITPR2—kidney cancer	5.23e-06	9.75e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APC—kidney cancer	4.86e-06	9.06e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KIT—kidney cancer	4.86e-06	9.06e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTT1—kidney cancer	4.77e-06	8.89e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ACHE—kidney cancer	4.77e-06	8.89e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MAPK3—kidney cancer	4.65e-06	8.67e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—POMC—kidney cancer	4.62e-06	8.62e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—BRAF—kidney cancer	4.56e-06	8.51e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SCARB1—kidney cancer	4.51e-06	8.42e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS1—kidney cancer	4.47e-06	8.33e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MAPK1—kidney cancer	4.42e-06	8.25e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PSMD7—kidney cancer	4.38e-06	8.17e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CA—kidney cancer	4.23e-06	7.88e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—KRAS—kidney cancer	4.18e-06	7.79e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—BCHE—kidney cancer	4.15e-06	7.75e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.1e-06	7.65e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.96e-06	7.39e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	3.84e-06	7.16e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RAF1—kidney cancer	3.81e-06	7.11e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RELA—kidney cancer	3.79e-06	7.08e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ERBB2—kidney cancer	3.77e-06	7.03e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MTOR—kidney cancer	3.72e-06	6.94e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	3.49e-06	6.51e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2—kidney cancer	3.42e-06	6.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCND1—kidney cancer	3.33e-06	6.21e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JUN—kidney cancer	3.32e-06	6.2e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTP1—kidney cancer	3.31e-06	6.16e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	3.3e-06	6.15e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTEN—kidney cancer	3.22e-06	6e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ABCB1—kidney cancer	3.13e-06	5.84e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTM1—kidney cancer	3.04e-06	5.66e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—kidney cancer	2.9e-06	5.42e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.88e-06	5.37e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK3—kidney cancer	2.75e-06	5.12e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MYC—kidney cancer	2.67e-06	4.98e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK1—kidney cancer	2.61e-06	4.87e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KRAS—kidney cancer	2.47e-06	4.6e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	2.27e-06	4.23e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TP53—kidney cancer	2.19e-06	4.09e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—POMC—kidney cancer	2.15e-06	4e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.71e-06	3.19e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTEN—kidney cancer	1.49e-06	2.79e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.05e-06	1.96e-05	CbGpPWpGaD
